Compounded tirzepatide

Remedy Meds

Remedy Meds costs $325 a month for compounded tirzepatide. It advertises $299. The card is charged $299 every 4 weeks.

A real month costs$325advertised $299 +$26.03 gap
EvidenceVerified
Billing cycle4-wk
Price across dosesSame at every dose
Where it shipsNot stated
FDA warning letterOne on filestill listed here

Visit Remedy Meds

The arithmeticOne month = 30.4375 days

  1. Remedy Meds advertises

    Read on Remedy Meds's own site

    $299.00

  2. The card is charged $299.00 — exactly what it advertises

    + $0.00

  3. And it is charged every 4 weeks, not every month

    13.04 charges a year, not twelve.

    + $26.03

A real month$325.03

A real month costs $26.03 more than the figure advertised.

Where it sits, and what costs less

$54median $199$325+

360 cheaper · 94%9 dearer · 2%

The most expensive 9 sellers charge between $325 and $500 a month.

  1. Fidelity Medical Clinicstarting dose$54
  2. Collective$76
  3. Embody$79
  4. NuuVim$79
  5. NextMeds$79
  6. Remedy Meds$325

Another 355 sellers are cheaper than Remedy Meds. The whole cheapest list →

Remedy Meds against other sellers

8 head-to-head comparisons use this seller. Each sets both receipts side by side on what the checkout bills over one calendar month.

What else this seller sells

The same seller appears in our data for one other medication.

  • tirzepatide$434 a month

Worked out the same way as the semaglutide price above, and kept separate from it.

FDA has written to this seller

On FDA issued warning letter 716830 to Remedy Meds of Summit , NJ 07901. Its stated subject:

Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)

Read the letter on fda.gov · The letter names remedymeds.com — the same site this page links to.

This seller stays in the index, at its real price. A warning letter is something you should see and weigh for yourself — an index that quietly dropped the worst records would be least useful exactly when it matters most. How we screen for these →